Gaye Bok leads Mass General Brigham’s $30M AI and Digital Innovation Venture Fund (AIDIF), investing in commercial-stage digital health companies, working with the Mass General Brigham system. Prior to joining Mass General Brigham, Gaye was a venture partner at an institutional venture fund, where she was an integral part of the investment team and served as a board director on several portfolio companies. Prior to venture investing, Gaye was an experienced commercial and business development executive, focused mainly on developing products and strategic partnerships across several verticals: Chemicals, genomics, biobased energy, and biobased products.
Gaye received an MBA in finance and international management from MIT’s Sloan School and an AB from Harvard and Radcliffe Colleges.